Abstract: A method of treating a malignant tumor selected from the group consisting of leukemia, colorectal cancer, ovarian cancer, oral cancer, lung carcinoma, breast carcinoma, prostate carcinoma, and melanoma by administering to a patient in need thereof an effective amount of at least one compound represented by formula (1) wherein A, X, Q, R1-3, and n are defined herein.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: The amino acid sequence of a mutant which is obtained by introducing a novel mutation into a Pseudonocardia thermophila JCM3095-derived nitrile hydratase consisting of two types of heterogeneous subunits, and the base sequence of the gene are provided. The nitrile hydratase is modified by specifying the region to be modified in the stereostructure/amino acid sequence of the nitrile hydratase, and applying alteration such as substitution, insertion, deletion or the like, to the amino acids in the amino acid sequence which are corresponding to the amino acid residues forming the region. Also provided is a method for modifying an enzyme having a nitrile hydratase activity.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: The amino acid sequence of a mutant which is obtained by introducing a novel mutation into a Pseudonocardia thermophila JCM3095-derived nitrile hydratase consisting of two types of heterogeneous subunits, and the base sequence of the gene are provided. The nitrile hydratase is modified by specifying the region to be modified in the stereostructure/amino acid sequence of the nitrile hydratase, and applying alteration such as substitution, insertion, deletion or the like, to the amino acids in the amino acid sequence which are corresponding to the amino acid residues forming the region. Also provided is a method for modifying an enzyme having a nitrile hydratase activity.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: A resin composition is provided for an electro-photographic toner. The composition comprises 5 to 95 parts by weight of a high molecular weight vinyl copolymer polymer and 95 to 5 parts by weight of a low molecular weight vinyl copolymer. The former ethylene polymer has a weight average molecular weight (Mw) of from 200,000 to 1,000,000 and a ratio (Mw/Mn) of the weight average molecular weight (Mw) to a number average molecular weight (Mn) of from 8 to 300, and the latter vinyl copolymer has a weight average molecular weight of from 3,000 to 20,000. At least one of the former and latter vinyl copolymer, preferably, the former vinyl copolymer is an ethylene polymer which has been obtained by conducting polymerization in the presence of a monomer having an ionization potential of from 10.0 to 15.0 eV and a difference of from 9.0 to 15.0 eV in level between a highest occupied molecular orbital (HOMO) and a lowest unoccupied molecular orbital (LUMO), both determined by computational chemistry.

Abstract: There are here provided a novel tetraphenylthiophene derivative represented by the general formula ##STR1## wherein AM is a tertiary amino group, each of l, m and n is the integer 0 or 1 and l.gtoreq.m.gtoreq.n are useful as the charge-transporting material in an electrophotographic photoreceptor having an electrically conductive base and a photosensitive layer thereon containing a charge-transporting material and a charge-generating material, which preferably is an azo compound.

Abstract: There are here provided a novel tetraphenylthiophene derivative represented by the general formula ##STR1## wherein AM is a tertiary amino group, each of l, m and n is the integer 0 or 1 and l.gtoreq.m.gtoreq.n are useful as the charge-transporting material in an electrophotographic photoreceptor having an electrically conductive base and a photosensitive layer thereon containing a charge-transporting material and a charge-generating material, which preferably is an azo compound.

Abstract: A temperature history indicator and its manufacturing method wherein the indicators are formed as chips, labels, tags or the like and accompanied with those goods or their packings which must be stored at a certain temperature or lower and when their storage temperature rises higher than the certain temperature over a not-permissible time period, this fact can be visibly shown by development or change of color caused by chemical matters in the indicator, characterized in that when temperature rises higher than a certain value, a hydrophobic organic compound enclosed in microcapsules melts and diffuses causing a dye-precursor and a color developer, which are prepared independently of the compound, to be contacted with each other to irreversibly achieve color development or change, that this color development or change system is rendered operative when the temperature rise continues to exceed a permissible time period, and that when the tops of the color development or change systems are coated with a transpare

Abstract: Disclosed herein is a novel benzoquinone derivative represented by the following general formula (I): ##STR1## wherein R.sub.1 means an alkyl or cycloalkyl group, R.sub.2 denotes an alkyl or cycloalkyl group, a phenyl group which may optionally contain one or more halogen atoms and/or alkyl, cycloalkyl, alkoxy, alkylene, phenoxy, phenyl and/or biphenylyl groups, or a benzyl or naphthyl group which may optionally contain one or more methyl groups. This compound is useful as an oxidative color-developing agent for recording materials.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.

Abstract: The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.